15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Veracyte Inc, 6 rate it Buy or better, 1 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $45.00 to $66.00, a moderate spread. The average target of $54.63 sits 2% below the current $55.63. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.44 next quarter toward $1.89 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy675%
Hold113%
Sell113%
Strong Sell00%
Based on 8 analysts giving stock ratings to Veracyte Inc.
As of Jul, 6 of 8 firms rate VCYT a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
VCYT EPS & revenue forecast
EPS · NEXT QUARTER
$0.44
Range $0.38 – $0.47 · 10 analysts · -14% YoY
Next period, 10 analysts expect Veracyte Inc to earn $0.44 a share (range $0.38 – $0.47), versus $0.51 a year earlier. Full-year consensus is $1.80, growing to $1.89 the year after.
REVENUE · NEXT QUARTER
$148.8M
Range $146.0M – $150.8M · 10 analysts · +13% YoY
Revenue is expected to reach $148.8M (range $146.0M – $150.8M), +12.9% year-over-year. Full-year consensus is $585.5M, rising to $654.9M next year.
Top analysts covering Veracyte Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on VCYT.
#1
KM
Kyle Mikson
Canaccord Genuity · Rank #192
Hold
$60.00+7.9% to target
Overall win rate
35%
+ Follow
#2
SJ
Sung Ji Nam
Scotiabank · Rank #196
Buy
$44.00-20.9% to target
Overall win rate
45%
+ Follow
#3
Mike Matson
Needham · Rank #204
Buy
$57.00+2.5% to target
Overall win rate
31%
+ Follow
#4
Matthew Sykes
Goldman Sachs · Rank #226
Hold
$37.00-33.5% to target
Overall win rate
37%
+ Follow
#5
David Westenberg
Piper Sandler · Rank #227
Buy
$66.00+18.6% to target
Overall win rate
31%
+ Follow
VCYT stock forecast FAQ
What is VCYT's average 12-month price target?+
The 8 analysts with a live target average $54.63 for Veracyte Inc over the next 12 months, ranging from a $66.00 high to a $45.00 low.
Is VCYT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 6 are Buy or Strong Buy, 1 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for VCYT?+
The Street-high target is $66.00 (Piper Sandler), and the Street-low is $45.00 (Jefferies). The average of all 8 active targets is $54.63.
How many Wall Street analysts cover VCYT?+
8 analysts have an active rating on Veracyte Inc, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering VCYT?+
Among analysts who currently cover VCYT, Kyle Mikson of Canaccord Genuity has the strongest overall Quantellect track record (Rank #192). Their current call is Hold with a $60.00 target.
What is Veracyte Inc's projected EPS for next quarter?+
The consensus estimate is $0.44 per share (range $0.38 – $0.47) across 10 analysts. Full-year EPS is projected at $1.80, rising to $1.89 the following year.
How much revenue is Veracyte Inc expected to report next quarter?+
Consensus revenue is $148.8M (range $146.0M – $150.8M). Full-year revenue is projected at $585.5M, growing to $654.9M next year.
Have analysts been upgrading or downgrading VCYT lately?+
As of Jul, 6 of 8 firms rate VCYT a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their VCYT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
